In Prevention of Blood clots Formation of blood clots blocks one or more veins, usually in your legs. V Parin 5000IU Injection is used to prevent formation of blood clots near the surface of your skin. It dissolves the clots and also relieves pain and inflammation by increasing the blood flow. This improves the overall healing process. V Parin 5000IU Injection is given as an injection by the doctor and should not be self-administered. The condition usually improves on its own in some time. Additionally, the doctor might recommend applying heat to the painful area, elevating the affected leg, using an over-the-counter painkiller and possibly wearing compression stockings.
It is unsafe to consume alcohol with V Parin 5000IU Injection.
V Parin 5000IU Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
V Parin 5000IU Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby. V Parin 5000IU Injection is released in small amounts in the breast milk and amounts reaching the baby are also small, which would not be expected to cause any harmful effects to the baby.
V Parin 5000IU Injection does not usually affect your ability to drive.
V Parin 5000IU Injection is safe to use in patients with kidney disease. No dose adjustment of V Parin 5000IU Injection is recommended. However, inform your doctor if you have any underlying kidney disease.
There is limited information available on the use of V Parin 5000IU Injection in patients with liver disease. Please consult your doctor.
If you miss a dose of V Parin 5000IU Injection, please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Chandra Bhagat Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Biological E Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Neon Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Celon Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Varenyam Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Biological E Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Elfin Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: United Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alna Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)